financial statements
The full income statement, balance sheet, and cash-flow statement for Thermo Fisher Scientific Inc. (TMO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 44.6B YoY+3.9% | 42.9B YoY+0.1% | 42.9B YoY-4.6% | 44.9B YoY+14.5% | 39.2B YoY+21.7% | |
| Research & development | 1.40B YoY+0.5% | 1.39B YoY+4.0% | 1.34B YoY-9.1% | 1.47B YoY+4.6% | 1.41B YoY+19.1% | |
| Selling, general & administrative | 8.73B YoY+1.6% | 8.60B YoY+1.8% | 8.45B YoY-6.1% | 8.99B YoY+12.3% | 8.01B YoY+15.5% | |
| Restructuring | 197M YoY+103.1% | 97.0M YoY-50.0% | 194M YoY+185.3% | 68.0M YoY+83.8% | 37.0M YoY-27.5% | |
| Amortization of intangibles | 1.73B YoY-11.4% | 1.95B YoY-16.5% | 2.34B YoY-2.4% | 2.40B YoY+36.0% | 1.76B YoY+5.6% | |
| Operating income | 7.75B YoY+5.6% | 7.34B YoY+7.0% | 6.86B YoY-18.3% | 8.39B YoY-16.3% | 10.0B YoY+28.7% | |
| Interest expense | 1.42B YoY+2.1% | 1.39B YoY+1.1% | 1.38B YoY+89.4% | 726M YoY+35.4% | 536M YoY-3.1% | |
| Interest & investment income | 993M YoY-7.9% | 1.08B YoY+22.6% | 879M YoY+223.2% | 272M YoY+532.6% | 43.0M YoY-33.8% | |
| Other non-operating income | -12.0M YoY-200.0% | 12.0M YoY+118.5% | -65.0M YoY+37.5% | -104M YoY+85.0% | -694M YoY-813.2% | |
| Equity-method income | -41.0M YoY+2.4% | -42.0M YoY+28.8% | -59.0M YoY+65.7% | -172M YoY-4200.0% | -4.00M YoY-33.3% | |
| Pre-tax income | 7.31B YoY+3.9% | 7.04B YoY+11.7% | 6.30B YoY-19.6% | 7.83B YoY-11.4% | 8.84B YoY+22.4% | |
| Income tax | 547M YoY-16.7% | 657M YoY+131.3% | 284M YoY-59.6% | 703M YoY-36.6% | 1.11B YoY+30.5% | |
6.72B YoY+6.0% | 6.34B YoY+6.4% | 5.96B YoY-14.4% | 6.96B YoY-9.9% | 7.73B YoY+21.2% | ||
$17.74 YoY+7.3% | $16.53 YoY+7.0% | $15.45 YoY-12.4% | $17.63 YoY-9.4% | $19.46 YoY+21.9% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
28.7B YoY+29.7% | 22.1B YoY-10.0% | 24.6B YoY-2.5% | 25.2B YoY+25.4% | 20.1B YoY-8.4% | ||
110B YoY+13.4% | 97.3B YoY-1.4% | 98.7B YoY+1.6% | 97.2B YoY+2.1% | 95.1B YoY+37.8% | ||
15.2B YoY+13.9% | 13.3B YoY-4.9% | 14.0B YoY-17.6% | 17.0B YoY+26.6% | 13.4B YoY+30.4% | ||
| Long-term debt | 39.2B YoY+26.1% | 31.1B YoY-10.5% | 34.7B YoY+1.3% | 34.3B YoY-1.1% | 34.7B YoY+81.5% | |
| Deferred revenue (non-current) | 1.18B YoY+4.0% | 1.14B YoY-24.1% | 1.50B YoY+27.1% | 1.18B YoY-4.8% | 1.24B YoY+62.3% | |
| Non-current lease liability | 1.20B YoY-3.6% | 1.24B YoY-0.4% | 1.24B YoY-5.3% | 1.31B YoY+9.1% | 1.20B YoY+92.2% | |
| Deferred tax liabilities | 1.49B YoY+17.7% | 1.27B YoY-34.0% | 1.92B YoY-32.5% | 2.85B YoY-25.7% | 3.84B YoY+113.9% | |
| Other non-current liabilities | 4.27B YoY+7.1% | 3.99B YoY-14.1% | 4.64B YoY+9.5% | 4.24B YoY-6.7% | 4.54B YoY+36.3% | |
53.4B YoY+7.7% | 49.6B YoY+6.1% | 46.7B YoY+6.3% | 44.0B YoY+7.8% | 40.8B YoY+18.2% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
7.82B YoY-9.8% | 8.67B YoY+3.1% | 8.41B YoY-8.2% | 9.15B YoY-1.7% | 9.31B YoY+12.3% | ||
-4.05B YoY+30.7% | -5.84B YoY-13.6% | -5.14B YoY-138.2% | -2.16B YoY+90.2% | -21.9B YoY-1352.5% | ||
1.80B YoY+126.5% | -6.79B YoY-87.5% | -3.62B YoY-28.9% | -2.81B YoY-142.7% | 6.58B YoY+586.2% | ||
| FX effect on cash | — | — | — | — | 194M YoY+10.2% | |
| Net change in cash | 5.84B YoY+243.9% | -4.06B YoY-822.0% | -440M YoY-110.9% | 4.05B YoY+169.2% | -5.84B YoY-173.9% | |
| Interest paid | 1.61B YoY+2.7% | 1.57B YoY+13.4% | 1.39B YoY+107.6% | 667M YoY+20.2% | 555M YoY+17.8% | |
| Income taxes paid | 1.78B YoY-3.2% | 1.83B YoY+23.8% | 1.48B YoY+20.1% | 1.23B YoY-43.4% | 2.18B YoY+64.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 218B YoY+9.4% | 199B YoY-3.0% | 205B YoY-5.0% | 216B YoY-17.9% | 263B YoY+42.4% | |
| P/E | 32.4× YoY+3.2% | 31.4× YoY-9.3% | 34.6× YoY+12.9% | 30.7× YoY-9.9% | 34.0× | |
| P/S | 4.9× YoY+5.3% | 4.6× YoY-1.7% | 4.7× YoY-3.4% | 4.9× YoY-27.1% | 6.7× YoY+17.0% | |
| P/B | 4.1× YoY+1.6% | 4.0× YoY-11.3% | 4.5× YoY-8.8% | 5.0× YoY-23.1% | 6.4× YoY+20.5% | |
| P/FCF | 34.6× YoY+26.3% | 27.4× YoY-12.6% | 31.3× YoY-18.8% | 38.6× YoY-0.4% | 38.7× YoY+43.0% | |
| Earnings yield | 3.1% YoY-3.1% | 3.2% YoY+10.3% | 2.9% YoY-11.5% | 3.3% YoY+11.0% | 2.9% | |
| FCF yield | 2.9% YoY-20.8% | 3.7% YoY+14.4% | 3.2% YoY+23.1% | 2.6% YoY+0.4% | 2.6% YoY-30.1% | |
| Dividend yield | 0.3% YoY-1.0% | 0.3% YoY+13.7% | 0.3% YoY+21.0% | 0.2% YoY+39.8% | 0.2% YoY-17.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: TMO's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TMO filings on SEC EDGAR → Not investment advice.
